Insulin Resistance Clinical Trial
Official title:
Microvascular Insulin Resistance and Mixed Meal Challenge
Verified date | April 2021 |
Source | Menzies Institute for Medical Research |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Insulin resistance (or pre-diabetes) is diagnosed using the oral glucose tolerance test. However, high blood glucose levels during this test may adversely impact on microvascular function. Investigators will determine whether a liquid mixed meal challenge (from carbohydrate, protein and fat) is a more appropriate test for assessing microvascular-derived insulin resistance.
Status | Active, not recruiting |
Enrollment | 45 |
Est. completion date | December 2021 |
Est. primary completion date | December 2021 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years to 70 Years |
Eligibility | Inclusion Criteria: - Aged 18-70 years. - Normal to overweight (BMI 19-35 kg/m2). - Normotensive (Seated brachial blood pressure <160/100 mmHg). - Considered healthy (HbA1c <6.5 %) or have clinically diagnosed type 2 diabetes. - Either have a parent with T2D, or no family history of type 2 diabetes for two generations. - Have given signed informed consent to participate in the study Exclusion Criteria: - Age <18 yrs or >70 yrs - Morbidly obese with a BMI =36 kg/m2 - History of myocardial infarction or stroke - History of malignancy within past 5 years (except for non-melanoma skin cancers) - Current smoker - History of severe liver disease - History of drug or alcohol abuse - Elective major surgery during the course of the study - Pregnancy/lactation - Participation or intention to participate in another clinical research study during the study period. |
Country | Name | City | State |
---|---|---|---|
Australia | Deakin University | Burwood | Victoria |
Australia | Menzies Institute for Medical Research | Hobart | Tasmania |
Lead Sponsor | Collaborator |
---|---|
Menzies Institute for Medical Research | Deakin University |
Australia,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change from baseline in muscle microvascular blood flow | Microvascular responses will be measured by contrast enhanced ultrasound before and 1hr after each challenge. | 1 hr | |
Secondary | Changes in blood glucose levels | Blood glucose levels will be measured at 0, 15, 30, 60, 90 and 120 min following each challenge. | 2 hr | |
Secondary | Changes in plasma insulin levels | Plasma insulin levels will be measured at 0, 15, 30, 60, 90 and 120 min following each challenge. | 2hr | |
Secondary | Changes in the respiratory exchange ratio (RER) | Changes in RER will be measured by metabolic cart during each challenge. | 1 hr |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03142633 -
MicroRNA as Biomarkers for Development of Metabolic Syndrome in Women With Polycystic Ovary Syndrome
|
||
Recruiting |
NCT04984226 -
Sodium Bicarbonate and Mitochondrial Energetics in Persons With CKD
|
Phase 2 | |
Recruiting |
NCT05354245 -
Using a Complex Carbohydrate Mixture to Steer Fermentation and Improve Metabolism in Adults With Overweight and Prediabetes (DISTAL)
|
N/A | |
Completed |
NCT03383822 -
Regulation of Endogenous Glucose Production by Brain Insulin Action in Insulin Resistance
|
Phase 1/Phase 2 | |
Recruiting |
NCT06007404 -
Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
|
||
Suspended |
NCT03652987 -
Endocrine and Menstrual Disturbances in Women With Polycystic Ovary Syndrome (PCOS)
|
||
Completed |
NCT04203238 -
Potato Research for Enhancing Metabolic Outcomes
|
N/A | |
Recruiting |
NCT03658564 -
Preoperative Oral Carbohydrate Treatment Minimizes Insulin Resistance
|
N/A | |
Completed |
NCT04183257 -
Effect of Escalating Oral Vitamin D Replacement on HOMA-IR in Vitamin D Deficient Type 2 Diabetics
|
Phase 4 | |
Completed |
NCT04117802 -
Effects of Maple Syrup on Gut Microbiota Diversity and Metabolic Syndrome
|
N/A | |
Completed |
NCT03627104 -
Effect of Dietary Protein and Energy Restriction in the Improvement of Insulin Resistance in Subjects With Obesity
|
N/A | |
Completed |
NCT05124847 -
TREating Pediatric Obesity
|
N/A | |
Active, not recruiting |
NCT03288025 -
Pulmonary Arterial Hypertension Improvement With Nutrition and Exercise (PHINE)
|
N/A | |
Completed |
NCT03809182 -
Effect of Dexmedetomidine on Postoperative Glucose and Insulin Levels.
|
Phase 4 | |
Completed |
NCT01809288 -
Identifying Risk for Diabetes and Heart Disease in Women
|
||
Completed |
NCT04642482 -
Synbiotic Therapy on Intestinal Microbiota and Insulin Resistance in Obesity
|
Phase 4 | |
Terminated |
NCT03278236 -
Does Time Restricted Feeding Improve Glycaemic Control in Overweight Men?
|
N/A | |
Not yet recruiting |
NCT06159543 -
The Effects of Fresh Mango Consumption on Cardiometabolic Outcomes in Free-living Individuals With Prediabetes
|
N/A | |
Withdrawn |
NCT04741204 -
Metformin Use to Reduce Disparities in Newly Diagnosed Breast Cancer
|
Phase 4 | |
Not yet recruiting |
NCT05540249 -
Pre-operative Carbohydrates in Diabetic Patients Undergoing CABG
|
N/A |